CY1105596T1 - Παραγωγα 2,4-δισυποκατεστημενης τριαζινης με δραση κατα του hiv - Google Patents
Παραγωγα 2,4-δισυποκατεστημενης τριαζινης με δραση κατα του hivInfo
- Publication number
- CY1105596T1 CY1105596T1 CY20061100457T CY061100457T CY1105596T1 CY 1105596 T1 CY1105596 T1 CY 1105596T1 CY 20061100457 T CY20061100457 T CY 20061100457T CY 061100457 T CY061100457 T CY 061100457T CY 1105596 T1 CY1105596 T1 CY 1105596T1
- Authority
- CY
- Cyprus
- Prior art keywords
- alkyl
- optionally substituted
- alkyloxycarbonyl
- nhc
- pyridazinyl
- Prior art date
Links
- 230000036436 anti-hiv Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 150000003918 triazines Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 2
- 125000002098 pyridazinyl group Chemical group 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 1
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 abstract 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 cyano, nitro, amino Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/42—One nitrogen atom
- C07D251/46—One nitrogen atom with oxygen or sulfur atoms attached to the two other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
- Y10S977/775—Nanosized powder or flake, e.g. nanosized catalyst
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Η εφεύρεση αναφέρεται στη χρήση των ενώσεων του τύπου (I), τα Ν-οξείδια, τα φαρμακευτικώς αποδεκτά άλατα πρόσθεσης, τις τεταρτοταγείς αμίνες και τις στερεοχημικά ισομερικές μορφές αυτών, όπου το -a1=a2-a3=a4- σχηματίζει μία φαινυλ, πυριδινυλ, πυριμιδινυλ, πυριδαζινυλ ή πυραζινυλ με την προσαρτημένη βινυλ ομάδα· το n είναι 0 έως 4· και όπου δυνατόν 5· το R1 είναι υδρογόνο, αρυλ, φορμυλ, C1-6αλκυλκαρβονυλ, C1-6αλκυλ, C1-6αλκυλοξυκαρβονυλ ή υποκατεστημένο C1-6αλκυλ· κάθε R2 ανεξάρτητα είναι υδροξυ, αλο, προαιρετικά υποκατεστημένο C1-6αλκυλ, C2-6αλκενυλ ή C2-6αλκυνυλ, C3-7κυκλοαλκυλ, C1-6αλκυλοξυ, C1-6αλκυλοξυκαρβονυλ, καρβοξυλ, κυανό, νίτρο, αμινο, μονο- ή δι(C1-6αλκυλ)αμινο, πολυαλομεθυλ, πολυαλομεθυλοξυ, πολυαλομεθυλθειο, -S(=O)pR4, -NH-S(=O)pR4, -C(=O)R4, -NHC(=O)H, -C(=O)NHNH2, -NHC(=O)R4, -C(=NH)R4 ή έναν 5-μελή ετεροκυκλικό δακτύλιο· το p είναι 1 ή 2· το L είναι προαιρετικά υποκατεστημένο C1-10αλκυλ, C2-10αλκενυλ, C2-10αλκυνυλ ή C3-7κυκλοαλκυλ· ή το L είναι -X-R3 όπου το R3 είναι προαιρετικά υποκατεστημένο φαινυλ, πυριδινυλ, πυριμιδινυλ, πυραζινυλ ή πυριδαζινυλ· το Χ είναι -NR1-, -ΝΗ-ΝΗ-, -Ν=Ν-, -Ο-, -C(=O)-, -CHOH-, -S-, -S(=O)- ή -S(=O)2-· το αρυλ είναι προαιρετικά υποκατεστημένο φαινυλ· για την παρασκευή ενός φαρμάκου για τη θεραπευτική αντιμετώπιση υποκειμένων που πάσχουν από λοίμωξη HIV (Ιός Ανθρώπινης Ανοσοανεπάρκειας).
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10779998P | 1998-11-10 | 1998-11-10 | |
| EP99203128 | 1999-09-24 | ||
| PCT/EP1999/008688 WO2000027828A2 (en) | 1998-11-10 | 1999-11-04 | 2,4-disubstituted triazine derivatives with anti hiv activity |
| EP99953980A EP1129079B1 (en) | 1998-11-10 | 1999-11-04 | 2,4-disubstituded triazine derivatives with anti hiv activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1105596T1 true CY1105596T1 (el) | 2010-07-28 |
Family
ID=26153374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20061100457T CY1105596T1 (el) | 1998-11-10 | 2006-03-31 | Παραγωγα 2,4-δισυποκατεστημενης τριαζινης με δραση κατα του hiv |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US6638932B1 (el) |
| EP (1) | EP1129079B1 (el) |
| JP (1) | JP2002529457A (el) |
| KR (1) | KR100620402B1 (el) |
| CN (1) | CN1207290C (el) |
| AP (1) | AP1636A (el) |
| AR (1) | AR021137A1 (el) |
| AT (1) | ATE315031T1 (el) |
| AU (1) | AU764472B2 (el) |
| BG (1) | BG65160B1 (el) |
| BR (1) | BR9915176A (el) |
| CA (1) | CA2351203C (el) |
| CY (1) | CY1105596T1 (el) |
| CZ (1) | CZ20011532A3 (el) |
| DE (1) | DE69929354T2 (el) |
| DK (1) | DK1129079T3 (el) |
| EA (1) | EA004501B1 (el) |
| EE (1) | EE200100253A (el) |
| ES (1) | ES2257081T3 (el) |
| HK (1) | HK1038232A1 (el) |
| HR (1) | HRP20010310A2 (el) |
| HU (1) | HUP0104395A3 (el) |
| ID (1) | ID28545A (el) |
| IL (2) | IL143024A0 (el) |
| MY (1) | MY126781A (el) |
| NO (1) | NO319788B1 (el) |
| NZ (1) | NZ510919A (el) |
| OA (1) | OA11675A (el) |
| PL (1) | PL196523B1 (el) |
| PT (1) | PT1129079E (el) |
| SI (1) | SI1129079T1 (el) |
| SK (1) | SK6022001A3 (el) |
| TR (1) | TR200101319T2 (el) |
| TW (1) | TW541305B (el) |
| WO (1) | WO2000027828A2 (el) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1129079T3 (da) * | 1998-11-10 | 2006-05-15 | Janssen Pharmaceutica Nv | 2,4-disubstituerede triazinderivater med anti-HIV aktivitet |
| DE19945982A1 (de) * | 1999-09-24 | 2001-03-29 | Knoll Ag | Geschwindigkeitsbestimmte Partikel |
| CA2406562C (en) | 2000-05-08 | 2009-09-15 | Janssen Pharmaceutica N.V. | Hiv replication inhibiting pyrimidines and triazines |
| AR039540A1 (es) * | 2002-05-13 | 2005-02-23 | Tibotec Pharm Ltd | Compuestos microbicidas con contenido de pirimidina o triazina |
| EA010379B1 (ru) | 2003-02-07 | 2008-08-29 | Янссен Фармацевтика Н.В. | Ингибирующие вич 1,2,4-триазины |
| AU2005271161B2 (en) | 2004-08-10 | 2011-05-12 | Janssen Pharmaceutica N.V. | HIV inhibiting 1,2,4-triazin-6-one derivatives |
| GB201204756D0 (en) * | 2012-03-19 | 2012-05-02 | Lewi Paulus J | Triazines with suitable spacers for treatment and/or prevention of HIV infections |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4927592B1 (el) * | 1970-05-13 | 1974-07-18 | ||
| BE754242A (fr) * | 1970-07-15 | 1971-02-01 | Geigy Ag J R | Diamino-s-triazines et dinitro-s-triazines |
| US4650867A (en) * | 1985-03-26 | 1987-03-17 | Ciba-Geigy Corporation | Process for the preparation of 2,4,6-tris(aminophenylamino)triazines |
| JPH02308248A (ja) | 1989-05-24 | 1990-12-21 | Fuji Photo Film Co Ltd | アミノピリミジン系色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料 |
| CZ101496A3 (en) | 1993-10-12 | 1996-11-13 | Du Pont Merck Pharma | N-alkyl-n-aryl-pyrimidinamines and derivatives thereof |
| US5691364A (en) * | 1995-03-10 | 1997-11-25 | Berlex Laboratories, Inc. | Benzamidine derivatives and their use as anti-coagulants |
| NO311614B1 (no) | 1996-10-01 | 2001-12-17 | Janssen Pharmaceutica Nv | Substituerte diamino-1,3,5-triazinderivater |
| IL137922A0 (en) | 1998-02-17 | 2001-10-31 | Tularik Inc | Anti-viral pyrimidine derivatives |
| DK1129079T3 (da) * | 1998-11-10 | 2006-05-15 | Janssen Pharmaceutica Nv | 2,4-disubstituerede triazinderivater med anti-HIV aktivitet |
-
1999
- 1999-11-04 DK DK99953980T patent/DK1129079T3/da active
- 1999-11-04 US US09/831,808 patent/US6638932B1/en not_active Expired - Fee Related
- 1999-11-04 EE EEP200100253A patent/EE200100253A/xx unknown
- 1999-11-04 JP JP2000581008A patent/JP2002529457A/ja active Pending
- 1999-11-04 EA EA200100534A patent/EA004501B1/ru not_active IP Right Cessation
- 1999-11-04 SI SI9930886T patent/SI1129079T1/sl unknown
- 1999-11-04 OA OA1200100114A patent/OA11675A/en unknown
- 1999-11-04 CA CA002351203A patent/CA2351203C/en not_active Expired - Fee Related
- 1999-11-04 CN CNB998130478A patent/CN1207290C/zh not_active Expired - Fee Related
- 1999-11-04 CZ CZ20011532A patent/CZ20011532A3/cs unknown
- 1999-11-04 HU HU0104395A patent/HUP0104395A3/hu unknown
- 1999-11-04 TR TR2001/01319T patent/TR200101319T2/xx unknown
- 1999-11-04 PL PL348145A patent/PL196523B1/pl not_active IP Right Cessation
- 1999-11-04 SK SK602-2001A patent/SK6022001A3/sk unknown
- 1999-11-04 DE DE69929354T patent/DE69929354T2/de not_active Expired - Fee Related
- 1999-11-04 PT PT99953980T patent/PT1129079E/pt unknown
- 1999-11-04 AU AU10462/00A patent/AU764472B2/en not_active Ceased
- 1999-11-04 AP APAP/P/2001/002155A patent/AP1636A/en active
- 1999-11-04 BR BR9915176-6A patent/BR9915176A/pt not_active IP Right Cessation
- 1999-11-04 KR KR1020017003574A patent/KR100620402B1/ko not_active IP Right Cessation
- 1999-11-04 IL IL14302499A patent/IL143024A0/xx active IP Right Grant
- 1999-11-04 ID IDW00200101017A patent/ID28545A/id unknown
- 1999-11-04 ES ES99953980T patent/ES2257081T3/es not_active Expired - Lifetime
- 1999-11-04 WO PCT/EP1999/008688 patent/WO2000027828A2/en active IP Right Grant
- 1999-11-04 NZ NZ510919A patent/NZ510919A/en unknown
- 1999-11-04 EP EP99953980A patent/EP1129079B1/en not_active Expired - Lifetime
- 1999-11-04 AT AT99953980T patent/ATE315031T1/de not_active IP Right Cessation
- 1999-11-05 MY MYPI99004801A patent/MY126781A/en unknown
- 1999-11-09 AR ARP990105681A patent/AR021137A1/es active IP Right Grant
- 1999-12-23 TW TW088119615A patent/TW541305B/zh not_active IP Right Cessation
-
2001
- 2001-04-06 BG BG105419A patent/BG65160B1/bg unknown
- 2001-04-19 NO NO20011934A patent/NO319788B1/no unknown
- 2001-05-02 HR HR20010310A patent/HRP20010310A2/hr not_active Application Discontinuation
- 2001-05-07 IL IL143024A patent/IL143024A/en not_active IP Right Cessation
- 2001-12-10 HK HK01108632A patent/HK1038232A1/xx not_active IP Right Cessation
-
2003
- 2003-08-27 US US10/649,017 patent/US7015221B2/en not_active Expired - Fee Related
-
2006
- 2006-03-31 CY CY20061100457T patent/CY1105596T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200100536A1 (ru) | Пиримидины, ингибирующие репликацию вич | |
| CY1105596T1 (el) | Παραγωγα 2,4-δισυποκατεστημενης τριαζινης με δραση κατα του hiv | |
| CY1112331T1 (el) | Παραγωγα πυριμιδινης που αναστελλουν τον hiv | |
| AP1475A (en) | Trisubstituted 1, 3, 5-triazine derivatives for treatment of HIV infections. | |
| AP1468A (en) | Hiv inhibiting pyrimidine derivatives. | |
| DK0580459T3 (da) | Substituerede phenylimidazolidiner, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf | |
| CY1106606T1 (el) | Διϋδροξυπυριμιδινο καρβοξαμιδια αναστολεις της ιντεγκρασης του hiv | |
| NO20021328L (no) | Pyrazolopyrimidier som terapeutiske midler | |
| MY176490A (en) | Pyrimidine derivatives for the prevention of hiv infection | |
| DE69823344D1 (de) | Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen | |
| TW200512208A (en) | Piperazine derivatives | |
| ATE500231T1 (de) | Hiv hemmende pyrimidin derivate | |
| KR940005612A (ko) | 벤조디아제핀 | |
| CY1125571T1 (el) | Πυριμιδινες που αναστελλουν τον πολλαπλασιασμο toy hiv | |
| MY118312A (en) | Angiogenesis inhibiting 5- substituted- 1,2,4- thiadiazolyl derivatives | |
| MX9707511A (es) | Derivados de diamino-1,3,5-triazina substituidos, su preparacion, composiciones que los contienen y el uso de los mismos. |